Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03248479
Title Hu5F9-G4 Monotherapy or Hu5F9-G4 in Combination With Azacitidine in Patients With Hematological Malignancies
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Forty Seven, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | GBR


No variant requirements are available.